|
Marc E. Lippman, M.D., has served as a Director of Seattle Genetics since June 2000. In May 2007, Dr. Lippman was named the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Leonard M. Miller School of Medicine, and Chairman of the Department of Medicine. Previously, he served as the John G. Searle Professor and Chairman of the Department of Internal Medicine at the University of Michigan School of Medicine. Before that, Dr. Lippman was the Director of the Lombardi Cancer Research Center, Professor and Chairman of the Department of Oncology, and Professor of Medicine at Georgetown University Medical School. He was also Chief of the Division of Hematology-Oncology and served as Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute. Dr. Lippman received his B.A., magna cum laude from Cornell (1964) and his M.D. from Yale where he was elected to Alpha Omega Alpha (1968). Dr. Lippman has received the Clinical Investigator Prize of the American Federation for Clinical Research, the Rosenthal Award of the American Association for Cancer Research, the American Cancer Society Lectureship awarded by the American Society for Clinical Oncology, the Astwood Prize of the Endocrine Society, and the Brinker International Prize for Basic Research in Breast Cancer. He has published over 400 peer-reviewed articles. In addition, he has authored several books and contributed many chapters based on his breast cancer research, including a textbook on breast disease. In addition to Seattle Genetics, Dr. Lippman is on the Board of Directors of Ascenta Therapeutics.
| 